News

3Qs: Drug Diagnosis

Bio­phar­ma­ceu­ti­cals, also known as bio­logics, are the fastest growing sector of the phar­ma­ceu­tical industry and most people living today will prob­ably take a bio­phar­ma­ceu­tical or know someone who takes one.

Read More

"Artificial liver” research featured on the Wall Street Journal's VentureWire blog

Research collaboration between the Department of Chemistry and Chemical Biology and Empiriko has led to development of a device, which has been heralded as an artificial liver.  The Biomimiks technology is designed to allow researchers to screen potential pharmaceuticals for toxic metabolites, bypassing the need for animal studies.  Work at Northeastern involves department chair Graham […]

Read More

Biochemistry program earns accreditation

In December, Northeastern University’s biochemistry program became one of the first four in the nation to be accredited through the American Society for Biochemistry and Molecular Biology (ASBMB) – indicating that it meets or exceeds professional standards, giving students an advantage with prospective employers and graduate schools.

Read More

Cancer research co-​​op points to exciting career path

When Mark Nan­iong, S’14, began his co-​​op at the Boston-​​based Belfer Insti­tute for Applied Cancer Sci­ences at Dana-​​Farber Cancer Insti­tute last spring, becoming a sci­en­tist wasn’t on his radar. But his expe­ri­en­tial learning oppor­tu­nity at the world-​​renowned treat­ment and research facility gave him a rare oppor­tu­nity to con­duct cut­ting edge research that could have major impli­ca­tions for the gen­eral public—an impact that this fifth-​​year chem­istry major hopes to cul­ti­vate in a future career in patent law. – See more at: http://www.northeastern.edu/news/2014/01/naniong/#sthash.Va4j7fzU.dpuf

Read More